Lolli, C., Verde, A., Degli Esposti, L., Acciai, V., Brigido, A., Proietti, E. and Scagliarini, S. (2024) “Cabozantinib use in second or subsequent line of treatment in renal cell carcinoma: an analysis of Italian administrative databases”, Global and Regional Health Technology Assessment, 11(1), pp. 154–160. doi: 10.33393/grhta.2024.2892.